Skip to main content
. 2021 Jan 29;11(1):e2021155. doi: 10.5826/dpc.1101a155

Table 1.

Classification of Skin Toxicities Induced by Checkpoint Inhibitors

Category Skin Disorder Frequency

Skin rashes/inflammatory dermatitis Maculopapular
Lichenoid
Psoriasiform
Eczematous
Neutrophilic dermatoses
Frequent
Frequent
Frequent
Frequent
Rare
Bullous eruptions Bullous pemphigoid, bullous lichen, lichen pemphigoides, linear IgA bullous dermatosis, bullous drug eruption Rare
Pruritus Isolated or in association with skin rashes Frequent
Pigmentary disorders Vitiligo
Regression of melanocytic nevi and other
pigmented lesions
Frequent
Less frequent
(pigmentary disorders are mainly seen among melanoma patients while it is rare in other tumors)
Severe cutaneous adverse reactions/life-threatening drug reactions Drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS)
Steven-Johnson syndrome (SJS)
Toxic epidermal necrolysis (TEN)
Acute generalized exanthematous pustulosis (AGEP)
Rare
Miscellaneous Grover disease
Vasculitis
Dermatomyositis
Sjögren syndrome
Sarcoidosis
Urticaria
Acneiform/papulopustular rocasea
Prurigo simplex/nodularis
Nail, hair, oral mucosa
Rare
Rare
Rare
Rare
Less frequent
Rare
Rare
Rare
Less frequent